Anti‐ epithelial cell adhesion molecule RNA aptamer‐conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model

Preparation and characterization of stable nanoliposomal formulations of curcumin with high loading efficacy: In vitro and in vivo anti-tumor study

(2020) Maryam Karimi et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma

(2020) Mohammad Mashreghi et al.   Nanoscale Research Letters

Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy

(2020) Parvin Zamani et al.   LIFE SCIENCES

MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer

(2019) Parvin Zamani et al.   JOURNAL OF CONTROLLED RELEASE

EpCAM Aptamer-Functionalized Cationic Liposome-Based Nanoparticles Loaded with miR-139-5p for Targeted Therapy in Colorectal Cancer

(2019) Yuyu Zhao et al.   MOLECULAR PHARMACEUTICS

Tumor targeting via EPR: Strategies to enhance patient responses

(2018) Susanne K. Golombek et al.   ADVANCED DRUG DELIVERY REVIEWS

A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy

(2018) Hamidreza Farzaneh et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer

(2017) Yang Li et al.   International Journal of Nanomedicine

PNC27 anticancer peptide as targeting ligand significantly improved antitumor efficacy of Doxil in HDM2-expressing cells

(2017) Shahrzad Amiri Darban et al.   Nanomedicine

Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model

(2016) Seyedeh Alia Moosavian et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice?

(2016) Shaghayegh Fathi et al.   Future Medicinal Chemistry

Multivalent Aptamers: Versatile Tools for Diagnostic and Therapeutic Applications

(2016) Mariya Vorobyeva et al.   MOLECULES

Aptamers: A promising chemical antibody for cancer therapy

(2016) Gang Zhou et al.   Oncotarget

Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin

(2015) Leila Arabi et al.   JOURNAL OF CONTROLLED RELEASE

Principles of nanoparticle design for overcoming biological barriers to drug delivery

(2015) Elvin Blanco et al.   NATURE BIOTECHNOLOGY

Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors

(2015) Dongxi Xiang et al.   Theranostics

Nucleic Acid Aptamers: New Methods for Selection, Stabilization, and Application in Biomedical Science

(2014) Hoon Young Kong et al.   Biomolecules & Therapeutics

EpCAM-targeted liposomal si-RNA delivery for treatment of epithelial cancer

(2014) Dhiraj Bhavsar et al.   DRUG DELIVERY

Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronan

(2014) Aditya G. Kohli et al.   JOURNAL OF CONTROLLED RELEASE

RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo

(2014) Si Eun Baek et al.   JOURNAL OF CONTROLLED RELEASE

Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas

(2013) Mohamadreza Amin et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Doxil® — The first FDA-approved nano-drug: Lessons learned

(2012) Yechezkel (Chezy) Barenholz   JOURNAL OF CONTROLLED RELEASE

RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule

(2011) Sarah Shigdar et al.   CANCER SCIENCE

Chimeric aptamers in cancer cell-targeted drug delivery

(2011) Jagat R. Kanwar et al.   CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

The Ligand Nanoparticle Conjugation Approach for Targeted Cancer Therapy

(2011) Nour Karra et al.   CURRENT DRUG METABOLISM

Specific Targeting of Ep-CAM in Various Carcinomas by Novel Monoclonal Antibodies

(2011) Devilakshmi Sithambaram et al.   HYBRIDOMA

Targeted drug delivery to tumors: Myths, reality and possibility

(2011) You Han Bae et al.   JOURNAL OF CONTROLLED RELEASE

EpCAM in carcinogenesis: the good, the bad or the ugly

(2010) B. T. F. van der Gun et al.   CARCINOGENESIS

To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery

(2010) Fabienne Danhier et al.   JOURNAL OF CONTROLLED RELEASE

A liposome-based nanostructure for aptamer directed delivery

(2009) Huaizhi Kang et al.   CHEMICAL COMMUNICATIONS